Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

June 21, 2022

Study Completion Date

June 29, 2022

Conditions

Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection

Interventions

DRUG

AXA1125

AXA1125 administered BID with or without food

DRUG

Placebo

Matching Placebo administered BID with or without food

Trial Locations (1)

Oxford University Hospitals NHS Foundation Trust, Oxford